Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections
US11273220B2 · kind B2 · utility
1Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2020 |
| Grant date | Mar 15, 2022 |
| Priority date | — |
| Expiry date | Jun 27, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention broadly provides different compositions, kits, vectors, and methods including monoclonal antibodies directed to epitopes found within lipoarabinomannan (LAM) and phosphatidyl-myo-inositol mannoside 6 (PIM6) for the diagnosis and treatment of Mycobacterium tuberculosis infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.